NCT04963374

Brief Summary

To compare the predictive effectiveness of the Caprini risk assessment model, the Padua risk assessment model and the VTE risk assessment in medical patients mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism on the risk of concomitant VTE in respiratory inpatients to provide a basis for clinical VTE assessment and treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.8 years

First QC Date

June 29, 2021

Last Update Submit

November 20, 2023

Conditions

Keywords

VTE

Outcome Measures

Primary Outcomes (1)

  • VTE incidence

    VTE incidence in patients with high risk of VTE

    during hospitalization, an average of 2 weeks

Study Arms (1)

respiratory inpatient

respiratory inpatient with VTE

Other: risk evolution scale

Interventions

Padua score、Caprini score、Prime score

respiratory inpatient

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

From January 2015 to December 2020, inpatients in respiratory department, Third Hospital of Peking University

You may qualify if:

  • age more than 18y respiratory inpatient

You may not qualify if:

  • Patients with deep vein thrombosis or pulmonary thromboembolism, sequelae of deep vein thrombosis, and thrombosis in other parts of lower limbs were diagnosed; Patients with severe coagulation dysfunction or other hematological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking UTH

Beijing, Beijing Municipality, 100191, China

Location

Related Publications (1)

  • Luo XY, Zhang FX. [Validation of the Caprini risk assessment model for venous thromboembolism in Chinese hospitalized patients in a general hospital]. Zhonghua Yi Xue Za Zhi. 2017 Jun 27;97(24):1875-1877. doi: 10.3760/cma.j.issn.0376-2491.2017.24.007. Chinese.

    PMID: 28648012BACKGROUND

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Jing Zhang, MD

    Peking UTH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 15, 2021

Study Start

April 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

November 22, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations